I. Iankov

发表

Oncolytic measles virus retargeting by ligand display.

E. Galanis, S. Russell, P. Msaouel, 2012, Methods in molecular biology.

The effect of chemical blockade of PKC with Gö6976 and Gö6983 on proliferation and MAPK activity in IL-6-dependent plasmacytoma cells.

V. Mitev, I. Mitov, Z. Tencheva, 2002, Leukemia research.

Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor.

S. Russell, Takafumi Nakamura, J. Merchan, 2009, Cancer research.

Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2

E. Galanis, D. Matern, Coleman T. Turgeon, 2021, Journal of Immunological Methods.

Engineering oncolytic measles virus to circumvent the intracellular innate immune response.

S. Russell, K. Peng, K. Hasegawa, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Heat shock protein inhibitors increase the efficacy of measles virotherapy

E. Galanis, S. Russell, C. Erlichman, 2008, Gene Therapy.

Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS).

J. Sarkaria, E. Galanis, M. Opyrchal, 2012, Human gene therapy.

Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells.

E. Galanis, A. R. Penheiter, M. Federspiel, 2013, Virus research.

Development of monoclonal antibody-based immunoassays for detection of Helicobacter pylori neutrophil-activating protein.

E. Galanis, A. R. Penheiter, S. K. Carlson, 2012, Journal of immunological methods.

Bactericidal Monoclonal Antibody Against Moraxella catarrhalis Lipooligosaccharide Cross-Reacts with Haemophilus Spp.

I. Mitov, I. Haralambieva, R. Gergova, 2007, Current Microbiology.

Monoclonal antibody against O:5 Salmonella antigen cross‐reacts with unidentified lipopolysaccharide epitope of Salmonella serogroup O:8 (C2–C3)

G. Georgiev, I. Mitov, I. Haralambieva, 2003 .

Production and characterization of monoclonal immunoglobulin A antibodies directed against Salmonella H:g,m flagellar antigen.

I. Mitov, I. Haralambieva, I. Iankov, 2002, FEMS immunology and medical microbiology.

Production and characterization of monoclonal immunoglobulin A antibodies directed against Salmonella H : g , m £ agellar antigen

I. Mitov, I. Haralambieva, V. Velev, 2002 .

Cross-reaction between the genus-specific lipopolysaccharide antigen of Chlamydia spp. and the lipopolysaccharides of Porphyromonas gingivalis, Escherichia coli O119 and Salmonella newington: implications for diagnosis.

I. Mitov, I. Haralambieva, I. Iankov, 2001, Diagnostic microbiology and infectious disease.

Monoclonal antibodies of IgA isotype specific for lipopolysaccharide of Salmonella enteritidis: production, purification, characterization and application as serotyping reagents.

I. Mitov, I. Haralambieva, I. Iankov, 2001, FEMS microbiology letters.

Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma

J. Sarkaria, E. Galanis, J. Ecsedy, 2016, Journal of Neuro-Oncology.

Monoclonal antibody of IgG isotype against a cross-reactive lipopolysaccharide epitope of Chlamydia and Salmonella Re chemotype enhances infectivity in L-929 fibroblast cells.

I. Mitov, I. Haralambieva, I. Iankov, 2002, FEMS immunology and medical microbiology.

Characterisation of 20-kDa lectin-spermagglutinin from Arum maculatum that prevents Chlamydia pneumoniae infection of L-929 fibroblast cells.

I. Mitov, I. Haralambieva, I. Iankov, 2002, FEMS immunology and medical microbiology.

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H.pylori immunostimulatory bacterial transgene

Minetta C. Liu, M. Goetz, E. Galanis, 2022, Molecular therapy. Methods & clinical development.

Attenuated oncolytic measles virus strains as cancer therapeutics.

E. Galanis, A. Dispenzieri, P. Msaouel, 2012, Current pharmaceutical biotechnology.

Measles virus expressed Helicobacter pylori neutrophil-activating protein significantly enhances the immunogenicity of poor immunogens.

E. Galanis, M. Federspiel, I. Iankov, 2013, Vaccine.

Cross-reactive monoclonal antibodies raised against the lipopolysaccharide antigen of Salmonella minnesota Re chemotype: diagnostic relevance.

I. Mitov, I. Haralambieva, I. Iankov, 2003, Diagnostic microbiology and infectious disease.

Monoclonal antibodies of IgA isotype specific for lipopolysaccharide of Salmonella enteritidis: production, purification, characterization and application as serotyping reagents.

I. Mitov, I. Haralambieva, I. Iankov, 2001, FEMS microbiology letters.

Protective efficacy of IgA monoclonal antibodies to O and H antigens in a mouse model of intranasal challenge with Salmonella enterica serotype Enteritidis.

I. Mitov, I. Haralambieva, O. Kalev, 2004, Microbes and infection.

Live Attenuated Measles Virus Vaccine Expressing Helicobacterpylori Heat Shock Protein A

E. Galanis, Arun Ammayappan, M. Federspiel, 2020, Molecular therapy oncolytics.

Immunoglobulin G Antibody-Mediated Enhancement of Measles Virus Infection Can Bypass the Protective Antiviral Immune Response

S. Russell, M. Federspiel, G. Griesmann, 2006, Journal of Virology.

Immune Response Can Bypass the Protective Antiviral Enhancement of Measles Virus Infection Immunoglobulin G Antibody-Mediated

S. Russell, M. Federspiel, E. Guy, 2006 .

Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter.

D. Tindall, E. Galanis, S. Russell, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα+ breast cancer cells

A. Degnim, J. Ingle, J. McCubrey, 2014, Oncogene.

Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1.

R. Ehman, M. Yin, S. Nyberg, 2017, The American journal of pathology.

Inhibition of Cdk2 kinase activity selectively targets the CD44+/CD24−/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells

J. Ingle, J. McCubrey, E. Galanis, 2014, International journal of oncology.

Engineered measles virus as a novel oncolytic therapy against prostate cancer

E. Galanis, M. Koutsilieris, R. Cattaneo, 2009, The Prostate.

Interleukin-13 Displaying Retargeted Oncolytic Measles Virus Strains Have Significant Activity Against Gliomas With Improved Specificity.

J. Sarkaria, R. Puri, E. Galanis, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Oncolytic measles virus strains in the treatment of gliomas

E. Galanis, S. Russell, K. Peng, 2008, Expert opinion on biological therapy.

Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells.

A. Degnim, J. Ingle, J. McCubrey, 2012, International journal of oncology.

Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy.

Aaron J. Johnson, E. Galanis, Arun Ammayappan, 2021, The Journal of clinical investigation.

Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.

J. Ingle, E. Galanis, S. Russell, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Converting tumor-specific markers into reporters of oncolytic virus infection.

A. Dietz, E. Galanis, Matthew L. Hillestad, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.

E. Galanis, I. Haralambieva, I. Iankov, 2011, Vaccine.

A key anti-viral protein, RSAD2/VIPERIN, restricts the release of measles virus from infected cells.

E. Galanis, I. Iankov, C. Kurokawa, 2019, Virus research.

Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy

E. Thompson, J. Sarkaria, A. Oberg, 2018, Journal of the National Cancer Institute.

Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.

S. Russell, M. Federspiel, B. Blechacz, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity.

J. Sarkaria, R. Puri, E. Galanis, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Inhibition of Rho-associated coiled-coil-forming kinase increases efficacy of measles virotherapy

E. Galanis, M. Opyrchal, P. Msaouel, 2013, Cancer Gene Therapy.

Chlamydophila pneumoniae induces p44/p42 mitogen-activated protein kinase activation in human fibroblasts through Toll-like receptor 4.

V. Mitev, I. Mitov, I. Haralambieva, 2004, Journal of medical microbiology.

KN-62 enhances Chlamydia pneumoniae-induced p44/p42 mitogen-activated protein kinase activation in murine fibroblasts and attenuates in vitro infection.

V. Mitev, I. Mitov, I. Haralambieva, 2002, FEMS microbiology letters.

Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells

A. Degnim, J. Ingle, J. McCubrey, 2017, Oncotarget.

Lipopolysaccharide-Specific but Not Anti-Flagellar Immunoglobulin A Monoclonal Antibodies Prevent Salmonella enterica Serotype Enteritidis Invasion and Replication within HEp-2 Cell Monolayers

I. Mitov, I. Haralambieva, I. Iankov, 2002, Infection and Immunity.

Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy

Asha A. Nair, Minetta C. Liu, J. Ingle, 2015, Cancer Gene Therapy.

Different Roles of the Three Loops Forming the Adhesive Interface of Nectin-4 in Measles Virus Binding and Cell Entry, Nectin-4 Homodimerization, and Heterodimerization with Nectin-1

P. Sinn, R. Cattaneo, M. Mateo, 2014, Journal of Virology.

Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model

A. Dietz, J. Ingle, E. Galanis, 2010, Breast Cancer Research and Treatment.

Personalizing Oncolytic Immunovirotherapy Approaches.

E. Galanis, I. Iankov, Georgios M Stergiopoulos, 2023, Molecular diagnosis & therapy.

Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy

Asha A. Nair, J. Ingle, E. Galanis, 2015, Cancer Gene Therapy.